Results 221 to 230 of about 22,901 (274)
Some of the next articles are maybe not open access.

Barrett’s esophagus

Endoscopy, 2005
Esophageal cancer staging is a widely accepted indication for endoscopic ultrasonography (EUS). The evaluation of Barrett's esophagus (BE) with EUS is indicated only when there is high-grade dysplasia or a concern for malignancy in an endoscopic lesion.
A, Rastogi, P, Sharma
openaire   +5 more sources

BARRETT'S ESOPHAGUS

Surgical Clinics of North America, 1997
The columnar replacement of squamous epithelium in the lower esophagus is the result of gastroesophageal reflux. Whether the squamous cells are replaced or undergo metaplasia is still conjectural. This neoepithelium is unstable in the presence of continued reflux and prone to complications of stricture, ulceration, and adenocarcinoma.
C G, Bremner, R M, Bremner
openaire   +4 more sources

Barrett Esophagus

Surgical Clinics of North America, 2015
Although there are many unanswered questions with Barrett esophagus, we can safely say that the incidence is increasing, chemoprevention strategies for the prevention of Barrett metaplasia and its progression to adenocarcinoma may be in the offing, surveillance should be considered for all patients who are discovered to have Barrett esophagus, RFA is ...
Mark, Splittgerber, Vic, Velanovich
openaire   +2 more sources

Barrett's esophagus

Journal of Gastrointestinal Surgery, 2004
Barrett's esophagus is an alteration of the esophageal epithelium, regardless of length, evidenced by endoscopic examination (protrusion of the gastric mucosa into the esophagus in the shape of a flame) and confirmed by histological examination of the bioptic samples (intestinal metaplasia with mucosecretory cells).
Jeffrey H, Peters   +2 more
openaire   +4 more sources

Barrett esophagus

Current Opinion in Gastroenterology, 2000
There continues to be great interest in Barrett esophagus, the premalignant lesion for adenocarcinoma of the esophagus and the esophagogastric junction. There were several publications this past year related to the epidemiology, pathogenesis, new methods for detection, biomarkers for stratifying patients by risk, and the treatment of patients with ...
P, Sharma, R E, Sampliner
openaire   +4 more sources

Barrett’s Esophagus

Current Treatment Options in Gastroenterology, 2014
Barrett's esophagus (BE) is the most important and recognizable precursor lesion for esophageal adenocarcinoma (EAC), which is the one of the fastest-growing cancers in the Western world (600 % in the U.S. in the last 40 years), and therefore it is critical to manage the risk of cancer present in BE.
Shanmugarajah, Rajendra, Prateek, Sharma
openaire   +2 more sources

Barrett Esophagus

Archives of Surgery, 1977
Barrett esophagus is the term describing the presence of an abnormal columnar epithelium in a portion of the esophagus. We have treated 19 patients within the past three years, representing almost 20% of all our esophageal experience; This one pathologic entity has presented as several different clinical pictures: benign stricture, peptic ulceration of
L R, Radigan   +3 more
openaire   +2 more sources

Barrettʼs esophagus

Current Opinion in Gastroenterology, 1988
Intestinal metaplasia in Barrett's esophagus is a major risk factor for esophageal adenocarcinoma, a tumor whose incidence rate has more than tripled in the United States over the past 2 decades. Studies have identified a number of molecular abnormalities that may be involved in the progression from dysplasia to cancer in Barrett's esophagus, including
openaire   +5 more sources

Barrett's Esophagus

Annals of Internal Medicine, 1982
Barrett's esophagus denotes the presence of columnar epithelium in the esophagus instead of the usual stratified squamous epithelium. Barrett's esophagus had been thought to represent a mediastinal extension of the stomach in patients with a congenital short esophagus.
E M, Bozymski   +2 more
openaire   +4 more sources

Barrett esophagus

Current Opinion in Internal Medicine, 2003
The importance of an in-depth understanding about Barrett esophagus is ultimately to decrease the mortality and morbidity from esophageal adenocarcinoma cancer by early detection of metaplasia and dysplasia and appropriate therapy. This review summarizes several publications in the past year related to the epidemiology, pathogenesis, screening and ...
Sanjeev, Slehria, Prateek, Sharma
openaire   +2 more sources

Home - About - Disclaimer - Privacy